Avancées dans la prévention et le dépistage précoce du cancer

Kirolos Eskandar

Abstract


Les stratégies de prévention et les technologies de détection précoce du cancer ont énormément évolué ces dernières années, améliorant considérablement le sort des patients. Cette revue de la littérature scientifique a pour but d’offrir aux infirmières en oncologie, et plus particulièrement à celles qui débutent dans ce domaine, des renseignements détaillés sur ces avancées. Il y sera question de l’adoption de vaccins anticancéreux, du changement de mode de vie et des technologies de détection de pointe – des éléments qui soulignent l’importance du dépistage génétique et génomique pour évaluer la prédisposition au cancer. En plus de faire état de certaines considérations éthiques, la revue porte un œil critique sur la contribution des infirmières en oncologie dans la promotion de ces mesures préventives, insistant sur l’importance des politiques de santé publique qui renforcent leur adoption. En présentant ces avancées, la revue propose une analyse détaillée de la situation et de ce qui est attendu en matière de prévention et de dépistage précoce du cancer, et rappelle l’importance d’améliorer les soins aux patients et les taux de survie.

Mots-clés : prévention du cancer, dépistage précoce, soins infirmiers en oncologie, technologies de détection, vaccins anticancéreux, dépistage génétique, IA en oncologie, considérations éthiques

10.5737/23688076354580


Full Text:

PDF

References


Akers, A. Y., Newmann, S. J., & Smith, J. S. (2007). Factors underlying disparities in cervical cancer incidence, screening and treatment in the United States. Current Problems in Cancer, 31(3), 157–181. https:doi.org/10.1016/j.current cancer.2007.01.001

Al Muhaisen, S., Safi, O., Ulayan, A., Aljawamis, S., Fakhoury, M., Baydoun, H., & Abuquteish, D. (2024). Artificial intelligence-powered mammography: Navigating the landscape of deep learning for breast cancer detection. Cureus, 16(3), e56945. https://doi.org/10.7759/cureus.56945

Arbyn, M., Xu, L., Simoens, C., & Martin-Hirsch, P. P. (2020). Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database of Systematic Reviews, (5), CD009069. https://doi.org/10.1002/14651858.CD009069.pub3

Baileys, K., McMullen, L., Lubejko, B., Christensen, D., Haylock, P. J., Rose, T., Sellers, J., & Srdanovic, D. (2018). Nurse navigator core competencies: An update to reflect the evolution of the role. Clinical Journal of Oncology Nursing, 22(3), 272–281. https://doi.org/10.1188/18.CJON.272-281

Björklund, M., Sarvimäki, A., & Berg, A. (2010). Living with head and neck cancer: A profile of captivity. Journal of Nursing and Healthcare of Chronic Illness, 2(1), 22–31. https://doi.org/10.1111/j.1752-9824.2010.01042.x

Chang, M. H., You, S. L., Chen, C. J., Liu, C. J., Lai, M. W., Wu, T. C., Wu, S. F., Lee, C. M., Yang, S. S., Chu, H. C., Wang, T. E., Chen, B. W., Chuang, W. L., Soon, M. S., Lin, C. Y., Chiou, S. T., Kuo, H. S., Chen, D. S., Yang, Y. J., … Cheng, Y. S. (2016). Long-term effects of hepatitis B immunization of infants in preventing liver cancer. Gastroenterology, 151(3), 472–480.e1. https://doi.org/10.1053/j.gastro.2016.05.048

Chen, A. M., Hsu, S., Felix, C., Garst, J., & Yoshizaki, T. (2018). Effect of psychosocial distress on outcome for head and neck cancer patients undergoing radiation. Laryngoscope, 128(3), 641–645. https://doi.org/10.1002/lary.26751

Clinton, S. K., Giovannucci, E. L., & Hursting, S. D. (2020). The World Cancer Research Fund/American Institute for Cancer Research third expert report on diet, nutrition, physical activity, and cancer: Impact and future directions. The Journal of Nutrition, 150(4), 663–671. https://doi.org/10.1093/jn/nxz268

Connal, S., Cameron, J. M., Sala, A., Brennan, P. M., Palmer, D. S., Palmer, J. D., Perlow, H., & Baker, M. J. (2023). Liquid biopsies: The future of cancer early detection. Journal of Translational Medicine, 21(1), 118. https://doi.org/10.1186/s12967-023-03960-8

Crosby, D., Bhatia, S., Brindle, K. M., Coussens, L. M., Dive, C., Emberton, M., Esener, S., Fitzgerald, R. C., Gambhir, S. S., Kuhn, P., Rebbeck, T. R., & Balasubramanian, S. (2022). Early detection of cancer. Science, 375(6586), eaay9040. https://doi.org/10.1126/science.aay9040

Dillner, J. (2019). Early detection and prevention. Molecular Oncology, 13(3), 591–598. https://doi.org/10.1002/1878-0261.12459

Division of Cancer Prevention. (2024). Early detection. National Cancer Institute. https://prevention.cancer.gov/research-groups/early-detection

Fan, T., Zhang, M., Yang, J., Zhu, Z., Cao, W., & Dong, C. (2023). Therapeutic cancer vaccines: Advancements, challenges, and prospects. Signal Transduction and Targeted Therapy, 8(1), 450. https://doi.org/10.1038/s41392-023-01674-3

Friebel-Klingner, T. M., Alvarez, G. G., Lappen, H., Pace, L. E., Huang, K. Y., Fernández, M. E., Shelley, D., & Rositch, A. F. (2024). State of the science of scale-up of cancer prevention and early detection interventions in low- and middle-income countries: A scoping review. JCO Global Oncology, 10, e2300238. https://doi.org/10.1200/GO.23.00238

Fund, J. (2021, April 20). How can genetic testing help early detection, risk reduction, and prevention of cancer? Jimmy Fund Blog. https://blog.jimmyfund.org/2021/02/how-can-genetic-testing-help-early-detection-risk-reduction-and-prevention-of-cancer/

Garland, S. M., Kjaer, S. K., Muñoz, N., Block, S. L., Brown, D. R., DiNubile, M. J., Lindsay, B. R., Kuter, B. J., Perez, G., Dominiak-Felden, G., Saah, A. J., Drury, R., Das, R., & Velicer, C. (2016). Impact and effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A systematic review of 10 years of real-world experience. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 63(4), 519–527. https://doi.org/10.1093/cid/ciw354

Genome Medicine. (2023). Advances in liquid biopsy approaches for early detection and monitoring of cancer. https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-018-0547-1

Ghazali, N., Roe, B., Lowe, D., Tandon, S., Jones, T., Shaw, R., Risk, J., & Rogers, S. N. (2017). Using the patients concerns inventory for distress screening in post-treatment head and neck cancer survivors. Journal of Cranio-Maxillofacial Surgery/Journal of Cranio-Maxillo-Facial Surgery, 45(10), 1743–1748. https://doi.org/10.1016/j.jcms.2017.07.009

Goodall, J., Mateo, J., Yuan, W., Mossop, H., Porta, N., Miranda, S., Perez-Lopez, R., Dolling, D., Robinson, D. R., Sandhu, S., Fowler, G., Ebbs, B., Flohr, P., Seed, G., Rodrigues, D. N., Boysen, G., Bertan, C., Atkin, M., Clarke, M., … TOPARP-A Investigators. (2017). Circulating cell-free DNA to guide prostate cancer treatment with PARP inhibition. Cancer Discovery, 7(9), 1006–1017. https://doi.org/10.1158/2159-8290.CD-17-0261

Gorski, D., & Gorski, D. (2008, May 11). The early detection of cancer and improved survival: More complicated than most people think. Science-Based Medicine. https://sciencebasedmedicine.org/the-early-detection-of-cancer-and-improved-survival-more-complicated-than-most-people-think/

Harvard T.H. Chan School of Public Health. (2023). The future of cancer prevention (part 1). https://www.hsph.harvard.edu/news/multimedia-article/cancer-prevention-podcast/

Henderson, J. T., Webber, E. M., Weyrich, M., Miller, M., & Melnikow, J. (2024, April 1). Screening for breast cancer: A comparative effectiveness review for the U.S. Preventive Services Task Force. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK603791/#ch4.s1

Henschke, C. (2023). Screening sharply improves lung cancer long-term survival. Radiological Society of North America (RSNA). https://www.rsna.org/news/2023/november/screening-improves-lung-cancer-survival

Juth, N., & Munthe, C. (2013). The ethics of screening in health care and medicine. The international library of ethics, law, and the new medicine. https://doi.org/10.1007/978-94-007-2045-9

Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., Xu, Y., Frohlich, M. W., & Schellhammer, P. F. (2010). Sipuleucel-T immunotherapy for castration-resistant prostate cancer. New England Journal of Medicine, 363(5), 411–422. https://doi.org/10.1056/nejmoa1001294

Levin, B., Lieberman, D. A., McFarland, B., Smith, R. A., Brooks, D., Andrews, K. S., Dash, C., Giardiello, F. M., Glick, S., Levin, T. R., Pickhardt, P., Rex, D. K., Thorson, A., & Winawer, S. J. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: A Cancer Journal for Clinicians, 58(3), 130–160. https://doi.org/10.3322/ca.2007.0018

Moleyar-Narayana, P., Leslie, S. W., & Ranganathan, S. (2024). Cancer screening. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK563138/

Molina-Montes, E., Ubago-Guisado, E., Petrova, D., Amiano, P., Chirlaque, M. D., Agudo, A., & Sánchez, M. J. (2021). The role of diet, alcohol, BMI, and physical activity in cancer mortality: Summary findings of the EPIC Study. Nutrients, 13(12), 4293. https://doi.org/10.3390/nu13124293

Nalley, C. (2020). A precision approach to cancer prevention & early detection. Oncology Times, 42(19), 27,31-31. https://doi.org/10.1097/01.cot.0000719340.05040.ea

National Cancer Institute. (2021, January 11). The Cancer Moonshot: A Midpoint Progress Update. https://www.cancer.gov/news-events/cancer-currents-blog/2021/cancer-moonshot-midpoint-progress-update

National Cancer Institute. (2024, February 21). NCI launches research network to evaluate emerging cancer screening technologies. [Press release]. https://www.cancer.gov/news-events/press-releases/2024/cancer-screening-research-network-launches

New York State Department of Health. (2019). Prevention agenda 2019–2024: New York State’s health improvement plan. https://www.health.ny.gov/prevention/prevention_agenda/2019-2024/

NHS England. (2019). NHS long term plan ambitions for cancer. https://www.england.nhs.uk/cancer/strategy/

Oncology Nursing Society (ONS). (2018). Role of the oncology nurse navigator throughout the cancer trajectory. Oncology Nursing Forum, 45(3), 283. https://doi.org/10.1188/18.ONF.283

Palmer, M., Sutherland, J., Barnard, S., Wynne, A., Rezel, E., Doel, A., Grigsby-Duffy, L., Edwards, S., Russell, S., Hotopf, E., Perel, P., & Free, C. (2018). The effectiveness of smoking cessation, physical activity/diet and alcohol reduction interventions delivered by mobile phones for the prevention of non-communicable diseases: A systematic review of randomised controlled trials. PloS One, 13(1), e0189801. https://doi.org/10.1371/journal.pone.0189801

American Cancer Society. (n.d.). Prevention and Early Detection Guidelines. https://www.cancer.org/health-care-professionals/american-cancer-society-prevention-early-detection-guidelines.html

Rajagopal, P. S., Nielsen, S., & Olopade, O. I. (2019). USPSTF Recommendations for BRCA1 and BRCA2 testing in the context of a transformative national cancer control plan. JAMA Network Open, 2(8), e1910142. https://doi.org/10.1001/jamanetworkopen.2019.10142

Rock, C. L., Thomson, C., Gansler, T., Gapstur, S. M., McCullough, M. L., Patel, A. V., Andrews, K. S., Bandera, E. V., Spees, C. K., Robien, K., Hartman, S., Sullivan, K., Grant, B. L., Hamilton, K. K., Kushi, L. H., Caan, B. J., Kibbe, D., Black, J. D., Wiedt, T. L., … Doyle, C. (2020). American Cancer Society guideline for diet and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians, 70(4), 245–271. https://doi.org/10.3322/caac.21591

Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., Lamba, S., Hobor, S., Avallone, A., Valtorta, E., Rospo, G., Medico, E., Motta, V., Antoniotti, C., Tatangelo, F., … Bardelli, A. (2015). Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nature Medicine, 21(7), 795–801. https://doi.org/10.1038/nm.3870

Sterba, K. R., Zapka, J., LaPelle, N., Garris, T. K., Buchanan, A., Scallion, M., & Day, T. (2017). Development of a survivorship needs assessment planning tool for head and neck cancer survivors and their caregivers: A preliminary study. Journal of Cancer Survivorship, 11(6), 822–832. https://doi.org/10.1007/s11764-017-0621-4

US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Jr, Kubik, M., Landefeld, C. S., Mangione, C. M., Pbert, L., Silverstein, M., Simon, M. A., Tseng, C. W., & Wong, J. B. (2019). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement. JAMA, 322(7), 652–665. https://doi.org/10.1001/jama.2019.10987

Verma, C., Pawar, V. A., Srivastava, S., Tyagi, A., Kaushik, G., Shukla, S. K., & Kumar, V. (2023). Cancer vaccines in the immunotherapy era: Promise and potential. Vaccines, 11(12), 1783. https://doi.org/10.3390/vaccines11121783

Zhang, B., Shi, H., & Wang, H. (2023). Machine learning and AI in cancer prognosis, prediction, and treatment selection: A critical approach. Journal of Multidisciplinary Healthcare, 16, 1779–1791. https://doi.org/10.2147/JMDH.S410301


Refbacks

  • There are currently no refbacks.